| Primary |
| Product Used For Unknown Indication |
54.7% |
| Prophylaxis |
5.0% |
| Thrombosis Prophylaxis |
5.0% |
| Thrombosis |
4.3% |
| Antiplatelet Therapy |
3.6% |
| Cerebrovascular Accident |
3.6% |
| Drug Use For Unknown Indication |
3.6% |
| Atrial Fibrillation |
2.9% |
| Acute Coronary Syndrome |
2.2% |
| Coronary Arterial Stent Insertion |
2.2% |
| Myocardial Ischaemia |
2.2% |
| Acute Myocardial Infarction |
1.4% |
| Coronary Artery Disease |
1.4% |
| Ischaemic Stroke |
1.4% |
| Morphoea |
1.4% |
| Post Procedural Pulmonary Embolism |
1.4% |
| Pulmonary Embolism |
1.4% |
| Cardiac Disorder |
0.7% |
| Cerebrovascular Accident Prophylaxis |
0.7% |
| Coronary Angioplasty |
0.7% |
|
| Urticaria |
10.3% |
| Rectal Haemorrhage |
7.7% |
| Shock Haemorrhagic |
7.7% |
| Vomiting |
7.7% |
| Drug Interaction |
5.1% |
| Dyspnoea |
5.1% |
| Haemorrhage |
5.1% |
| Medication Error |
5.1% |
| Muscle Disorder |
5.1% |
| Myocardial Infarction |
5.1% |
| Spontaneous Haematoma |
5.1% |
| Suicidal Ideation |
5.1% |
| Thrombosis In Device |
5.1% |
| White Blood Cell Count Increased |
5.1% |
| Abdominal Pain |
2.6% |
| Abdominal Pain Upper |
2.6% |
| Alveolitis Allergic |
2.6% |
| Asthenia |
2.6% |
| Cerebral Haemorrhage |
2.6% |
| Cholecystitis Acute |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
62.5% |
| Coronary Artery Disease |
6.3% |
| Hypertension |
4.5% |
| Anticoagulant Therapy |
3.6% |
| Cardiac Disorder |
2.7% |
| Ischaemic Heart Disease Prophylaxis |
2.7% |
| Thrombolysis |
2.7% |
| Atrial Fibrillation |
1.8% |
| Cardiac Operation |
1.8% |
| Percutaneous Coronary Intervention |
1.8% |
| Platelet Aggregation Inhibition |
1.8% |
| Post Procedural Complication |
1.8% |
| Stent Placement |
1.8% |
| Acute Myocardial Infarction |
0.9% |
| Arteriogram Coronary |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Hyperthyroidism |
0.9% |
| Temporal Arteritis |
0.9% |
|
| Laceration |
9.1% |
| Rhabdomyolysis |
9.1% |
| Angioedema |
4.5% |
| Cheilitis |
4.5% |
| Drug Prescribing Error |
4.5% |
| Duodenal Ulcer Haemorrhage |
4.5% |
| Exposure During Pregnancy |
4.5% |
| Haematuria |
4.5% |
| Haemoglobin Decreased |
4.5% |
| Haemoptysis |
4.5% |
| Hepatitis Cholestatic |
4.5% |
| Intentional Drug Misuse |
4.5% |
| International Normalised Ratio Increased |
4.5% |
| Laryngeal Oedema |
4.5% |
| Leukopenia |
4.5% |
| Melaena |
4.5% |
| Mitral Valve Hypoplasia |
4.5% |
| Multi-organ Disorder |
4.5% |
| Myocardial Infarction |
4.5% |
| Nausea |
4.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.7% |
| Hypertension |
12.4% |
| Diabetes Mellitus |
9.8% |
| Depression |
8.5% |
| Myocardial Infarction |
3.9% |
| Colorectal Cancer Metastatic |
3.3% |
| Ill-defined Disorder |
3.3% |
| Gout |
2.6% |
| Peritoneal Dialysis |
2.6% |
| Plasma Cell Myeloma |
2.6% |
| Urinary Tract Infection |
2.6% |
| Drug Use For Unknown Indication |
2.0% |
| Analgesic Therapy |
2.0% |
| Bladder Disorder |
2.0% |
| Blood Cholesterol Increased |
2.0% |
| Cerebrovascular Accident |
2.0% |
| Gastrointestinal Stromal Tumour |
2.0% |
| Hypercholesterolaemia |
2.0% |
| Immunosuppression |
2.0% |
| Onychomycosis |
2.0% |
|
| Renal Failure Acute |
9.4% |
| Urinary Retention |
7.5% |
| Vascular Stent Insertion |
7.5% |
| Heart Rate Irregular |
5.7% |
| Lower Respiratory Tract Infection |
5.7% |
| Medication Error |
5.7% |
| Paraesthesia |
5.7% |
| Renal Impairment |
5.7% |
| Vomiting |
5.7% |
| Convulsion |
3.8% |
| Malaise |
3.8% |
| Memory Impairment |
3.8% |
| Myalgia |
3.8% |
| Pruritus |
3.8% |
| Pulmonary Oedema |
3.8% |
| Pyrexia |
3.8% |
| Sepsis |
3.8% |
| Skin Exfoliation |
3.8% |
| Somnolence |
3.8% |
| Tenosynovitis |
3.8% |
|
